Introduction: Type C hepatitis, an infectious disease considered a global health problem, presents risks for congenital malformation, low weight and higher rates of perinatal mortality, and its condition may induce an increase in the maternal mortality rate. Objective: Verify epidemiological aspects of type C Hepatitis in pregnant women in city of Belém of state of Pará. Methodology: It is a descriptive research with information from DATASUS-SINAN database, which seven filters were used to obtain the epidemiological data of pregnant women, aged between 10 to 59 years old, in the period from January of 2008 to December of 2018, with laboratory confirmation for type C virus, anti-HCV reagent serology. Results: 510 cases of pregnant women with type C hepatitis were reported, with anti-HCV serology confirmation, noting that the second trimester of pregnancy had showed the highest absolute number with 12 cases (2.35%) of infected pregnant women, followed by the third trimester with 07 cases (1.37%) and the first trimester with 05 cases (0.98%), respectively. It was found that 17 cases (3.33%) did not correspond to any of the gestational periods, being ignored or in the "blank" section of the database. Most pregnant women (70.83%) comprised the age group of 20 to 39 years old; 6.9% represent cases of inconclusive fulminant hepatitis; 3.13% acute type C hepatitis and 88.82% chronic type C hepatitis; whose main route of contamination was sexual (5.68%). Conclusion: Therefore, type C hepatitis occurs mainly between the second and third trimesters, with sexual and injectable transmission, which reinforces the importance of a wellperformed prenatal care, allowing for early measures to be taken.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.